In our final batch of Changing Faces columns for 2025, we’re detailing a flurry of senior leadership appointments in recent ...
AdvanCell Pty Ltd (“AdvanCell”), a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Philina Lee, PhD as Chief ...
Dr Lee is a seasoned biopharmaceutical executive with a proven track record of leading cross-functional teams to successfully develop and commercialize innovative therapies in oncology SYDNEY & BOSTON ...
Dr Lee is a seasoned biopharmaceutical executive with a proven track record of leading cross-functional teams to successfully develop and commercialize innovative therapies in oncology AdvanCell Pty ...
Australian clinical-stage radiopharmaceutical company AdvanCell today announced the appointment of Philina Lee as chief executive (CEO) and a member of the board of directors. Dr Lee will head ...
AdvanCell Pty Ltd, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, has appointed Philina Lee, PhD as Chief Executive Officer and member of the ...
Hosted on MSN
DBV Technologies Appoints Dr. Philina Lee to Board
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. DBV Technologies SA – American ( (DBVT)) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback